Biosimilars Blog
RF 360


Insightful. Precise. Skilled.

Steven Lieberman and Jennifer P. Nock at BIO Intellectual Property Counsels Committee Spring Conference

From Allegation to Adjudication: Preparing for Patent Litigation


April 11, 2018 — April 13, 2018

Partner Steven Lieberman and associate Jennifer P. Nock will participate in a panel during the Biotechnology Innovation Organization (BIO) Intellectual Property Counsels Committee (IPCC) Spring Conference being held April 11-13, 2018, in New Orleans, LA.

The panel, titled "From Allegation to Adjudication: Preparing for Patent Litigation," will cover how to prepare for litigation in Hatch-Waxman and biosimilar cases. Speakers will offer practical tips on how to prepare your strongest case, prepare a budget, select litigation counsel, identify and retain experts, preserve documents, select a favorable venue, determine a litigation strategy, manage IPRs, position a case for settlement and for trial, and more. The panel is targeted at smaller companies that may have little or no experience litigating patent issues, but will offer insights and updates for seasoned litigators as well. Come with your questions for this lively panel of in-house and outside counsel who will share their experiences as both defendants and plaintiffs.

The panel will take place at 2 pm on the second day of the conference, April 12. Participants include Steven Lieberman as the moderator, and Dan Troy, Senior Vice President and General Counsel of GlaxoSmithKline (GSK), John Weidenbruch, General Counsel of Epizyme, and Jennifer Nock as panelists.

For more information, and to register for the conference, please visit the BIO IPCC Spring 2018 event page.